Literature DB >> 16225399

Constitutional and somatic RB1 mutation spectrum in nonfamilial unilateral and bilateral retinoblastoma in India.

M N Bamne1, P N Ghule, J Jose, S D Banavali, P A Kurkure, P S Amare Kadam.   

Abstract

An epidemiologic survey has indicated a comparatively high prevalence of retinoblastoma (Rb) in Asian countries. Recently, the development of preventive strategies in nonfamilial Rb has become a major goal. The present studies were designed for identification and characterization of constitutional and somatic RB1 gene mutations by conventional cytogenetics, fluorescent in situ hybridization (FISH) and polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP)-DNA sequencing. Of 34 patients 32 were nonfamilial and 2 were familial Rb. Maternal inheritance of del (13q14) was common. FISH was sensitive in detecting monoallelic RB1 deletion/deletion mosaicism as a first genetic hit in 20% of cases. Somatic and germline RB1 point mutations affected exons 3, 17, 20, and 21 and these were identified as novel mutations. Involvement of exon 20 as a predisposing mutation in sporadic unilateral retinoblastoma (URB) probably suggests the susceptibility of exon 20 to unknown etiologic factors in our population. A de novo RB1 deletion along with transmitted RB1 point mutation from an asymptomatic parent was identified as a unique predisposing RB1 mutation chimerism in a URB case that later evolved to bilateral retinoblastoma (BRB). The predisposing mutations such as del (13q), RB1 mono-allelic deletion and RB1 point mutation in sporadic Rb were de novo as well as transmitted mutations from asymptomatic/symptomatic parents. The RB1 mutation incidence was comparatively higher (25%) in nonfamilial Rb with emphasis on high prevalence in sporadic URB (18% versus 0%-9% in the literature series). The present studies demonstrated the efficacy of a multitechnique approach to detect various types of constitutional RB1 mutations such as RB1 deletion, deletion mosaicism, point mutation, mutation chimerism in patients of symptomatic/asymptomatic parents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225399     DOI: 10.1089/gte.2005.9.200

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  6 in total

1.  Analysis of retinoblastoma age incidence data using a fully stochastic cancer model.

Authors:  Mark P Little; Ruth A Kleinerman; Charles A Stiller; Guangquan Li; Mary E Kroll; Michael F G Murphy
Journal:  Int J Cancer       Date:  2011-06-10       Impact factor: 7.396

2.  A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients.

Authors:  Kannan Thirumalairaj; Aloysius Abraham; Bharanidharan Devarajan; Namrata Gaikwad; Usha Kim; Veerappan Muthukkaruppan; Ayyasamy Vanniarajan
Journal:  J Hum Genet       Date:  2015-06-18       Impact factor: 3.172

3.  A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma.

Authors:  Vidya Latha Parsam; Chitra Kannabiran; Santosh Honavar; Geeta K Vemuganti; Mohammad Javed Ali
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

4.  Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.

Authors:  Jaya Singh; Avshesh Mishra; Arunachalam Jayamuruga Pandian; Ashwin C Mallipatna; Vikas Khetan; S Sripriya; Suman Kapoor; Smita Agarwal; Satish Sankaran; Shanmukh Katragadda; Vamsi Veeramachaneni; Ramesh Hariharan; Kalyanasundaram Subramanian; Ashraf U Mannan
Journal:  Mol Vis       Date:  2016-08-16       Impact factor: 2.367

5.  Spectrum of mutations in the RB1 gene in Vietnamese patients with retinoblastoma.

Authors:  Nguyen Cong Kiet; Le Thai Khuong; Do Duc Minh; Nguyen Huynh Minh Quan; Phan Thi Xinh; Nguyen Ngoc Chau Trang; Nguyen Thanh Luan; Nguyen Minh Khai; Hoang Anh Vu
Journal:  Mol Vis       Date:  2019-04-04       Impact factor: 2.367

6.  Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling.

Authors:  Swati Tomar; Raman Sethi; Gangadhara Sundar; Thuan Chong Quah; Boon Long Quah; Poh San Lai
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.